Synergism between HIV and other viruses in the mouth

被引:30
作者
Mbopi-Kéou, FX
Bélec, L
Teo, CG
Scully, C
Porter, SR
机构
[1] Univ London, Eastman Dent Inst Oral Hlth Care Sci, Dept Oral Med, UCL, London WC1X 8LD, England
[2] Publ Hlth Lab Serv, PHLS, London, England
[3] Hop Europeen Georges Pompidou, Paris, France
[4] Univ Paris 06, Paris, France
关键词
D O I
10.1016/S1473-3099(02)00317-1
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The HIV family replicate in and are shed from the mouth. Oral sexual practices potentially contribute to the overall extent of HIV transmission, particularly if high-risk practices are not restricted. Herpesviruses and papillomaviruses that appear in the oral cavity can determine oral HIV replication. The mechanisms probably include heterologous transactivation, enhanced expression of HIV receptors and co-receptors in target cells, release of cytokines and chemokines, and production of superantigens. Oral diseases peculiar to, or more common in, the HIV-infected patient further predispose to heightened oral HIV replication and trafficking. Defining the mechanisms by which oral viruses interact with HIV in the co-infected host should permit intervention measures against oral HIV transmission to be more precisely targeted.
引用
收藏
页码:416 / 424
页数:9
相关论文
共 131 条
[1]   Intrapartum mucosal exposure to human immunodeficiency virus type 1 (HIV-1) of infants born to HIV-1-infected mothers correlates with maternal plasma virus burden [J].
Ait-Khaled, M ;
Lyall, EGH ;
Stainsby, C ;
Taylor, GP ;
Wright, A ;
Weber, JN ;
McClure, MO ;
Tudor-Williams, G .
JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (04) :1097-1100
[2]   Enhanced interleukin 1β, interleukin 6 and tumor necrosis factor α in gingival crevicular fluid from periodontal pockets of patients infected with human immunodeficiency virus 1 [J].
Baqui, AAMA ;
Meiller, TF ;
Jabra-Rizk, MA ;
Zhang, M ;
Kelley, JI ;
Falkler, WA .
ORAL MICROBIOLOGY AND IMMUNOLOGY, 2000, 15 (02) :67-73
[3]   Why is HIV rarely transmitted by oral secretions? Saliva can disrupt orally shed, infected leukocytes [J].
Baron, S ;
Poast, J ;
Cloyd, MW .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (03) :303-310
[4]  
BELEC L, 2001, TRANSMISSION SEXUELL
[5]  
BERGEY EJ, 1994, J ACQ IMMUN DEF SYND, V7, P995
[6]   Cytokine profiles in parotid saliva from HIV-1-infected individuals: changes associated with opportunistic infections in the oral cavity [J].
Black, KP ;
Merrill, KW ;
Jackson, S ;
Katz, J .
ORAL MICROBIOLOGY AND IMMUNOLOGY, 2000, 15 (02) :74-81
[7]   Infection of Macaca nemestrina neonates with HIV-1 via different routes of inoculation [J].
Bosch, ML ;
Schmidt, A ;
Agy, MB ;
Kimball, LE ;
Morton, WR .
AIDS, 1997, 11 (13) :1555-1563
[8]   Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines [J].
Boshoff, C ;
Endo, Y ;
Collins, PD ;
Takeuchi, Y ;
Reeves, JD ;
Schweickart, VL ;
Siani, MA ;
Sasaki, T ;
Williams, TJ ;
Gray, PW ;
Moore, PS ;
Chang, Y ;
Weiss, RA .
SCIENCE, 1997, 278 (5336) :290-294
[9]   Risk factors associated with Epstein-Barr virus replication in oral epithelial cells of HIV-infected individuals [J].
Boulter, AW ;
Soltanpoor, N ;
Swan, AV ;
Birnbaum, W ;
Johnson, NW ;
Teo, CG .
AIDS, 1996, 10 (09) :935-940
[10]   Human herpesvirus-8 (Kaposi's sarcoma-associated herpesvirus) ORF50 interacts synergistically with the tat gene product in transactivating the human immunodeficiency virus type 1 LTR [J].
Caselli, E ;
Menegazzi, P ;
Bracci, A ;
Galvan, M ;
Cassai, E ;
Di Luca, D .
JOURNAL OF GENERAL VIROLOGY, 2001, 82 :1965-1970